These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38277740)

  • 21. Comprehensive functional profiling of long non-coding RNAs through a novel pan-cancer integration approach and modular analysis of their protein-coding gene association networks.
    Walters K; Sarsenov R; Too WS; Hare RK; Paterson IC; Lambert DW; Brown S; Bradford JR
    BMC Genomics; 2019 Jun; 20(1):454. PubMed ID: 31159744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNAs and cancer mechanisms: Immune cells and inflammatory cytokines in the tumor microenvironment.
    Yang P; Ding J; Bian Y; Ma Z; Wang K; Li J
    Med Oncol; 2022 May; 39(7):108. PubMed ID: 35578054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An extensive overview of the role of lncRNAs generated from immune cells in the etiology of cancer.
    Luo H; Jing H; Chen W
    Int Immunopharmacol; 2024 May; 133():112063. PubMed ID: 38677091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of T cell differentiation and function by long noncoding RNAs in homeostasis and cancer.
    Erber J; Herndler-Brandstetter D
    Front Immunol; 2023; 14():1181499. PubMed ID: 37346034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long non-coding RNAs within the tumour microenvironment and their role in tumour-stroma cross-talk.
    Del Vecchio F; Lee GH; Hawezi J; Bhome R; Pugh S; Sayan E; Thomas G; Packham G; Primrose J; Pichler M; Mirnezami A; Calin G; Bullock M
    Cancer Lett; 2018 May; 421():94-102. PubMed ID: 29458141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exosomal lncRNAs and cancer: connecting the missing links.
    Naderi-Meshkin H; Lai X; Amirkhah R; Vera J; Rasko JEJ; Schmitz U
    Bioinformatics; 2019 Jan; 35(2):352-360. PubMed ID: 30649349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction Among Noncoding RNAs, DNA Damage Reactions, and Genomic Instability in the Hypoxic Tumor: Is it Therapeutically Exploitable Practice?
    Ray SK; Mukherjee S
    Curr Mol Med; 2023; 23(3):200-215. PubMed ID: 35048804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA
    Botti G; Scognamiglio G; Aquino G; Liguori G; Cantile M
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31072041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic value and immune landscaps of m6A/m5C-related lncRNAs signature in the low grade glioma.
    Li R; Chen H; Li C; Qi Y; Zhao K; Wang J; You C; Huang H
    BMC Bioinformatics; 2023 Jul; 24(1):274. PubMed ID: 37403043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
    Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
    BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long non-coding RNA and the tumor microenvironment: Prospects for clinical applications in breast cancer.
    Lei Y; He J; Tang Y
    Crit Rev Oncol Hematol; 2023 Oct; 190():104102. PubMed ID: 37597792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
    Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
    Front Immunol; 2021; 12():806189. PubMed ID: 35095893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling.
    Entezari M; Ghanbarirad M; Taheriazam A; Sadrkhanloo M; Zabolian A; Goharrizi MASB; Hushmandi K; Aref AR; Ashrafizadeh M; Zarrabi A; Nabavi N; Rabiee N; Hashemi M; Samarghandian S
    Biomed Pharmacother; 2022 Jun; 150():112963. PubMed ID: 35468579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment.
    Xu Z; Chen Y; Ma L; Chen Y; Liu J; Guo Y; Yu T; Zhang L; Zhu L; Shu Y
    Mol Ther; 2022 Oct; 30(10):3133-3154. PubMed ID: 35405312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
    Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
    BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of lncRNAs in the tumor microenvironment and immunotherapy of melanoma.
    Zhou W; Xu X; Cen Y; Chen J
    Front Immunol; 2022; 13():1085766. PubMed ID: 36601121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in the study of exosomal lncRNAs in tumors and the selection of research methods.
    Wu Y; Wang Y; Wei M; Han X; Xu T; Cui M
    Biomed Pharmacother; 2020 Mar; 123():109716. PubMed ID: 31896067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long noncoding RNA: an emerging paradigm of cancer research.
    Qiu MT; Hu JW; Yin R; Xu L
    Tumour Biol; 2013 Apr; 34(2):613-20. PubMed ID: 23359273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long non-coding RNA implicated in the invasion and metastasis of head and neck cancer: possible function and mechanisms.
    Luo X; Qiu Y; Jiang Y; Chen F; Jiang L; Zhou Y; Dan H; Zeng X; Lei YL; Chen Q
    Mol Cancer; 2018 Jan; 17(1):14. PubMed ID: 29368602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long noncoding RNAs as regulators of cancer immunity.
    Denaro N; Merlano MC; Lo Nigro C
    Mol Oncol; 2019 Jan; 13(1):61-73. PubMed ID: 30499165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.